Jushi Holdings (JUSHF) Depreciation and Depletion (2021 - 2026)
Jushi Holdings (JUSHF) reported Depreciation and Depletion of $4.0 million for Q1 2026, down 10.93% year-over-year from $4.5 million in Q1 2025, and up 17.98% quarter-over-quarter from $3.4 million in Q4 2025.
Jushi Holdings (JUSHF) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Depreciation and Depletion data on file, last reported at $4.0 million in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $4.0 million, down 10.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.1 million (down 12.94% YoY), and the FY2025 annual result was $16.6 million, down 12.21% from the prior year.
- Depreciation and Depletion grew to $4.0 million in Q1 2026 per JUSHF's latest filing, from $3.4 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $12.8 million in Q4 2022 and troughed at $2.6 million in Q1 2022.
- A 5-year average of $4.8 million and a median of $4.5 million in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion jumped 266.47% in 2022, then sank 62.13% in 2023.
- A 5-year view of Depreciation and Depletion shows it stood at $12.8 million in 2022, then slumped by 62.13% to $4.9 million in 2023, then decreased by 8.31% to $4.4 million in 2024, then declined by 23.58% to $3.4 million in 2025, then increased by 17.98% to $4.0 million in 2026.
- Business Quant data shows JUSHF's Depreciation and Depletion at $4.0 million in Q1 2026, $3.4 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.01 Mn |
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 4.21 Mn |
| Sep 30, 2025 | 4.21 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 4.45 Mn |
| Dec 31, 2024 | 4.45 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 4.97 Mn |
| Mar 31, 2024 | 4.91 Mn |
| Mar 31, 2024 | 4.91 Mn |
| Dec 31, 2023 | 4.85 Mn |
| Dec 31, 2023 | 4.85 Mn |